DocGo (NASDAQ:DCGO – Get Free Report) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its rivals? We will compare DocGo to related companies based on the strength of its profitability, analyst recommendations, institutional ownership, valuation, risk, dividends and earnings.
Profitability
This table compares DocGo and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -60.96% | -63.66% | -33.31% |
| DocGo Competitors | -1.05% | -139.10% | -2.48% |
Insider & Institutional Ownership
56.4% of DocGo shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 5.1% of DocGo shares are owned by company insiders. Comparatively, 14.9% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Risk and Volatility
DocGo has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, DocGo’s rivals have a beta of 0.97, indicating that their average share price is 3% less volatile than the S&P 500.
Valuation and Earnings
This table compares DocGo and its rivals gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| DocGo | $297.34 million | -$182.40 million | -0.09 |
| DocGo Competitors | $19.34 billion | $301.67 million | -3.54 |
DocGo’s rivals have higher revenue and earnings than DocGo. DocGo is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Analyst Ratings
This is a summary of current ratings and recommmendations for DocGo and its rivals, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 1 | 2 | 0 | 2.25 |
| DocGo Competitors | 1890 | 7763 | 13430 | 841 | 2.55 |
DocGo currently has a consensus target price of $1.50, suggesting a potential upside of 757.14%. As a group, “Healthcare Providers & Services” companies have a potential upside of 21.92%. Given DocGo’s higher probable upside, equities analysts clearly believe DocGo is more favorable than its rivals.
Summary
DocGo rivals beat DocGo on 9 of the 13 factors compared.
DocGo Company Profile
DocGo Inc. is a healthcare services company that delivers medical care and patient transportation outside traditional healthcare facilities. Its services include mobile healthcare programs, in-home and community-based care, and ambulance transportation. The company uses a technology platform to coordinate clinicians, emergency medical technicians and other healthcare professionals. Its mobile services support healthcare providers, government agencies and other organizations seeking to deliver care in homes and community settings.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
